|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 227.01 USD | -0.19% |
|
-2.93% | -0.65% |
| 03-10 | AbbVie Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 11:20 AM | |
| 03-09 | AbbVie says CEO Robert Michael's 2025 total compensation was $32.5 million - SEC filing | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 236.19 | 244.38 | 236.28 |
| Spread/Res. | -3.89% | -7.11% | -3.92% |
| Spread/Supp. | +1.03% | +7.10% | +11.53% |
| Support | 224.69 | 211.96 | 203.55 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ABBV Stock
- Charts AbbVie Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition